top of page

🔷 Integrated Biospecimen Collection & Laboratory Support:

We provide end-to-end biospecimen solutions across our embedded SMO network, supporting biomarker-driven, translational, and clinical research programs.

Core capabilities:

  • Patient identification & EMR-driven prescreening

  • Multi-site sample collection across Florida & Puerto Rico

  • Standardized processing (PBMC, plasma, serum, tissue)

  • Temperature-controlled storage (-80°C & LN2)

  • Chain of custody and compliant logistics

  • ​

Through our partnership with a fully equipped laboratory with over 15 years of experience, we ensure high-quality processing, storage, and compliance across all biospecimen workflows.

​

Scalable, High-Quality Biospecimen Collection Within a Real Clinical Network

Research Management Partners (RMP) delivers end-to-end biospecimen collection programs through an embedded clinical research network operating within active healthcare practices across Florida and Puerto Rico, with the ability to rapidly scale across the United States.

Our model provides Sponsors, CROs, and biobanking organizations with direct access to diverse, pre-qualified patient populations (>1.2M patients across our MSO network), enabling fast activation, consistent execution, and protocol-compliant sample collection at scale.

Typical operational performance includes:

  • Study start-up timelines: 2–4 weeks from activation to first patient

  • High protocol adherence and sample integrity under standardized SOPs

  • Real-time operational oversight across all participating sites

  • ​

🔷 What We Do

RMP supports the full lifecycle of biospecimen collection programs:

  • Patient identification and recruitment through EMR-integrated workflows

  • IRB-compliant informed consent and enrollment (as applicable)

  • Biospecimen collection performed by medically trained clinical staff

  • On-site processing and preparation per protocol specifications

  • IATA-compliant packaging and shipment

  • Real-time tracking, documentation, and chain-of-custody management

Our integrated model minimizes variability, protects sample integrity, and ensures consistent cross-site execution under centralized oversight.

​

🔷 Types of Biospecimens Supported

We support a broad range of protocol-driven collections:

  • Whole blood

  • Serum and plasma

  • Peripheral Blood Mononuclear Cells (PBMC)

  • DNA and RNA samples

  • Tissue samples (protocol-dependent)

  • Stool and urine

All collections are executed under study-specific protocols, SOPs, and applicable regulatory frameworks.

​

🔷 Infrastructure & Operational Readiness

RMP provides a scalable operational infrastructure designed for high-performance execution:

  • Dedicated laboratory environments for sample handling and processing

  • Temperature-controlled workflows aligned with protocol requirements

  • IATA-certified personnel for compliant packaging and shipment

  • Standardized SOPs deployed across all affiliated sites

  • Centralized regulatory, operational, and quality oversight

All teams operate under GCP-aligned quality systems to ensure audit-ready performance and regulatory compliance.

​

🔷 Operational Capacity

RMP is capable of supporting both targeted and large-scale biospecimen programs:

  • Multi-site deployment across 10–25+ active sites

  • Rapid site activation through pre-qualified clinical locations

  • Access to diverse patient populations across multiple therapeutic areas

  • Flexible scaling based on protocol complexity and enrollment targets

​

🔷 The RMP Advantage

Unlike traditional biobanks or broker-based collection models, RMP operates directly within active clinical care environments, enabling:

  • Immediate access to real-world patient populations

  • Accelerated recruitment through embedded clinical workflows

  • High protocol adherence driven by continuity of care

  • Standardized, high-quality sample collection across all sites

  • Real-time operational visibility and centralized oversight

Our embedded SMO model ensures biospecimen collection is fully integrated into patient care delivery—not performed in isolation.

​

🔷 Use Cases & Program Types

RMP supports a wide range of biospecimen-driven programs, including:

  • Biomarker discovery and validation programs

  • Longitudinal sample collection studies

  • Oncology and specialty disease screening initiatives

  • Gastroenterology and metabolic disease sample collection

  • Infectious disease and vaccine-related programs

  • Real-world evidence (RWE) and observational sample collection

​

🔷 Who We Partner With

RMP collaborates with:

  • Biobanking organizations seeking U.S.-based collection infrastructure

  • Contract Research Organizations (CROs) managing multi-site programs

  • Pharmaceutical and biotechnology sponsors requiring reliable patient-driven sample acquisition

We serve as the site-level execution partner, responsible for patient engagement, operational delivery, and protocol compliance.

​

🔷 Pilot Program Approach

To accelerate onboarding and reduce operational risk, RMP offers pilot programs across 2–3 sites to validate:

  • Recruitment performance

  • Operational efficiency

  • Sample quality and protocol adherence

Pilot programs can be deployed within 2–4 weeks and expanded rapidly across the broader network based on performance outcomes.

​

🔷 Get Started

If you are planning or expanding a biospecimen collection program, RMP provides rapid deployment, scalable infrastructure, and reliable site-level execution.

Request a Pilot Program, Feasibility Assessment, or Capability

​

             
                                                            admin@rmpsmo.com


                                786-464-0868

                          Response within 24 hours

bottom of page